前收市價 | 1.7800 |
開市 | 2.6000 |
買盤 | 1.2500 |
賣出價 | 3.4000 |
拍板 | 25.00 |
到期日 | 2024-06-21 |
今日波幅 | 2.6000 - 2.6000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 92 |
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.